Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Neuromuscular Management: Quantitative TOF-Guided Sugammadex Versus Spontaneous Recovery for Early Extubation in Pediatric Minimally Invasive Cardiac Surgery (A Prospective Observational Cohort Study)

NCT07798011 is registered in ClinicalTrials.gov with Dr. Nguyen Thi Thu Hang as lead sponsor.

NCT NCT07798011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07798011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Neuromuscular Management: Quantitative TOF-Guided Sugammadex Versus Spontaneous Recovery for Early Extubation in Pediatric Minimally Invasive Cardiac Surgery (A Prospective Observational Cohort Study)
Lead sponsor
Dr. Nguyen Thi Thu Hang
Phase
Observational
Overall status
Recruiting
Start date
December 4, 2025
Completion date
December 31, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asd - atrial septal defect, early extubation pathway, minimally invasive pediatric cardiac surgery, pediatric cardiac surgery, tof-guided sugammadex administration